BRIEF published on 04/30/2024 at 13:05, 1 year 7 months ago Emmecell Completes Final Cell Therapy Dosing in U.S. Clinical Trial for Corneal Edema Clinical Trial Cell Therapy Emmecell Corneal Edema Non-surgical Treatment
BRIEF published on 04/30/2024 at 13:05, 1 year 7 months ago Emmecell achève le dosage final de la thérapie cellulaire dans le cadre d'un essai clinique américain sur l'œdème cornéen Thérapie Cellulaire Essai Clinique Emmecell Œdème Cornéen Traitement Non Chirurgical
PRESS RELEASE published on 04/30/2024 at 13:00, 1 year 7 months ago Emmecell Completes Final Cell Therapy Dosing in U.S. Clinical Trial for Corneal Edema Emmecell completes final dose administration for the last patient in U.S. trial for EO2002, a non-surgical cell therapy for corneal edema, showing promise for treating vision loss Clinical Trial Cell Therapy Emmecell Corneal Edema EO2002
Published on 12/05/2025 at 02:35, 4 hours 4 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 39 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 34 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 39 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 9 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 48 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 14 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 24 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 29 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:14, 12 hours 25 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 39 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 39 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 54 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 54 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
